David D. Halbert - 06 Mar 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 17:55:42 UTC
Previous filing
13 Aug 2025
Next filing
18 May 2026

Key filing fact

David D. Halbert filed Form 4 for Caris Life Sciences, Inc. (CAI) on 10 Mar 2026.

Key facts

  • This page summarizes David D. Halbert's Form 4 filing for Caris Life Sciences, Inc. (CAI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 10 Mar 2026, 17:55.

Change

  • Previous filing in this sequence was filed on 13 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001034380 Primary reporting owner

HALBERT DAVID D

Relationship
Founder, Chairman, and Chief Executive Officer, Director, 10%+ Owner
Address
C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Signature date
10 Mar 2026

Transactions Table

CAI transaction

Common Stock

Award

Transaction value
Shares
+320,112
Change %
+14%
Price
$0.000000*
Shares after
2,615,245
Date
06 Mar 2026
Ownership
Direct
Footnotes
F1
CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
121,025,002
Date
06 Mar 2026
Ownership
See Footnotes
Footnotes
F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
F2 The Common Stock reported herein includes (i) 76,261,532 shares of Common Stock held of record by Caris Halbert, L.P., (ii) 8,528,805 shares of Common Stock held of record by ADAPT I Ltd., (iii) 8,414,427 shares of Common Stock held of record by Carisome I, L.P., (iv) 645,149 shares of Common Stock held of record by Caris Investment II Ltd, (v) 2,175,089 shares of Common Stock held of record by Caris Investment III Ltd, and (vi) 25,000,000 shares held of record by Halbert Family Capital, LLC. Caris Investment Management, LLC is the general partner of each of Caris Halbert, L.P., Caris Investment II Ltd., and Caris Investment III Ltd. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. Caris Halbert, L.P. is the managing member of Halbert Family Capital, LLC.
F3 David Dean Halbert is the managing member of Caris Investment Management, LLC and the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein.

Remarks:

Founder, Chairman, and Chief Executive Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .